The Company would like to clarify that the Notification Letter has no current effect on the listing or trading of the Company's securities on Nasdaq. Pursuant to Rule 5810 (c) (3) (A) of the Nasdaq ...

CHARLOTTE, N.C., June 10, 2025 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced it will be added to the broad-market Russell 3000 ® Index following the annual reconstitution of the ...

Having previously identified a panel of candidate mRNA biomarkers with potential clinical relevance, Mainz Biomed will now begin the verification process in collaboration with Crown Bioscience, a ...

TAIPEI (Taiwan News) — Two university students returned safely to Taiwan on Saturday evening after being held and forced to work at a scam center in Cambodia. The two friends, both students in ...

TAIPEI (Taiwan News) — The Centers for Disease Control said Thursday the mandatory interval between two COVID jabs for an estimated 760,000 people in high-risk groups will be shortened to 60 days. As ...

TAIPEI (Taiwan News) — Anonymous on Monday hacked into two Russian websites and posted Taiwan flags in solidarity with Ukraine's major drone attack on Russian bombers. An Anonymous representative who ...

TAIPEI (Taiwan News) — The Ministry of National Defense tracked 16 Chinese military aircraft, eight naval vessels, and one official ship around Taiwan between 6 a.m. on Thursday and 6 a.m. on Friday.

Report Ocean has published a new report on the Saudi Arabia Telecom Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

Participants can choose between the Chinese and the English interpretation lines. Please note that the English interpretation option will be in listen-only mode. Please dial in 15 minutes before the ...

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases ...

At present, there is no ICI-based drug combination for the treatment of advanced MSS colorectal cancer, which is a cold tumor. Studies have shown that epigenetic regulators such as class I HDAC ...

LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), clinical-stage biopharmaceutical company developing cell therapies for AL ...